Previous 10 | Next 10 |
Search all articles related articles and news articles from the OTCMKTS NASDAQ and NYSE markets.
Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncont...
Simon Hale, a Senior Portfolio Manager at Wellington Altus Private Wealth, has highlighted the potential for Tesla Inc. (NASDAQ:TSLA) to reach new ...
The $1 billion AI project between Microsoft Corporation (NASDAQ:MSFT) and United Arab Emirates AI holding company G42 in Kenya has come under the...
The $1 billion AI project between Microsoft Corporation (NASDAQ:MSFT) and United Arab Emirates AI holding company G42 in Kenya has come under the...
The $1 billion AI project between Microsoft Corporation (NASDAQ:MSFT) and United Arab Emirates AI holding company G42 in Kenya has come under the...
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, i...
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, i...
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, i...
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, i...
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory, i...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.03%Change Percent:
Pieris Pharmaceuticals Inc. Company Name:
PIRS Stock Symbol:
NASDAQ Market:
pieris.com Website: